Last quarter (Q ), Nu-Med Plus's total revenue was $-3.00K, a decrease of -Infinity% from the same quarter last year. In Q, Nu-Med Plus's net income was $-63.20K. See Nu-Med Plus’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ -3.00K	-	-	-	$ 0.00	$ 0.00
Cost of Revenue	-	-	-	-	-	-
Gross Profit	$ -3.00K	-	-	-	-	-
Operating Expense	$ 45.04K	$ 120.53K	$ 182.17K	$ 839.45K	$ 1.99M	$ 1.02M
Operating Income	$ -57.83K	$ -120.53K	$ -182.17K	$ -839.45K	$ -1.99M	$ -1.02M
Net Non Operating Interest Income Expense	$ -4.74K	$ -5.00K	$ -1.00K	-	$ -14.32K	$ -17.39K
Other Income Expense	$ -50.00K	-	$ -53.00K	$ -9.38K	-	-
Pretax Income	$ -25.77K	$ -125.53K	$ -130.17K	$ -830.06K	$ -2.01M	$ -1.04M
Tax Provision	-	-	-	-	$ 0.00	$ 0.00
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -25.77K	$ -125.53K	$ -104.22K	$ -830.06K	$ -2.01M	$ -1.04M
Basic EPS	-	-	-	$ -0.01	$ -0.04	$ -0.02
Diluted EPS	-	-	-	$ -0.01	$ -0.04	$ -0.02
Basic Average Shares	$ 325.30M	$ 81.67M	$ 79.95M	$ 73.37M	$ 54.51M	$ 45.55M
Diluted Average Shares	$ 325.30M	$ 81.67M	$ 79.95M	$ 73.37M	$ 54.51M	$ 45.55M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	$ 18.76K	$ 18.68K
Total Expenses	$ 45.04K	$ 120.53K	$ 182.17K	$ 839.45K	$ 1.99M	$ 1.02M
Net Income From Continuing And Discontinued Operation	$ -66.51K	$ -125.53K	$ -130.17K	$ -830.06K	$ -2.01M	$ -1.04M
Normalized Income	$ -69.14K	$ -99.17K	-	-	$ -2.01M	$ -1.04M
Interest Expense	-	-	-	-	$ 14.32K	$ 17.41K
EBIT	$ -21.03K	$ -120.53K	$ -129.17K	$ -830.06K	$ -1.99M	$ -1.02M
EBITDA	$ 2.04K	$ -120.53K	$ -118.68K	$ -820.70K	$ -1.97M	$ -994.97K

Currency in USD

Nu-Med Plus Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing